A. Ganatra

Non‐oral HRT and lipoprotein metabolism. Which progestin — dydrogesterone or medroxyprogesterone acetate?

R. Bhathena, A. Ganatra, R. Pinto, 2000, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

The management of malignant ureteral obstruction treated with ureteral stents.

K. Loughlin, A. Ganatra, 2005, The Journal of urology.

The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins.

R. Bhathena, A. Ganatra, R. Pinto, 1998, British journal of clinical pharmacology.

The current status of laparoscopic sacrocolpopexy: a review.

E. Barret, X. Cathelineau, F. Rozet, 2009, European urology.

Cost of malignant ureteral obstruction treated with ureteral stents

K. Loughlin, A. Ganatra, 2007 .

A transition to laparoendoscopic single-site surgery (LESS) radical prostatectomy: human cadaver experimental and initial clinical experience.

E. Barret, X. Cathelineau, F. Rozet, 2009, Journal of endourology.

The treatment of hypertriglyceridaemia in menopausal women with transdermal oestradiol therapy

R. Bhathena, A. Ganatra, B. Anklesaria, 1999, British journal of obstetrics and gynaecology.

The influence of medroxyprogesterone acetate on the effects of transdermal oestradiol replacement therapy on plasma lipids.

R. Bhathena, A. Ganatra, R. Pinto, 1998, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

Skin reactions with transdermal estradiol therapy in a tropical environment

A. Ganatra, R.K Bhathena, B.S Anklesaria, 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.